We have typed 9 EBV cell lines from azoospermic or severely oligospermic patients for the expression of H-Y antigen, in order to test the hypothesis of the coinddence of AZF and HYA genes. Of nine patients with cytogenetically normal Υ chromosomes, 7 could be tested for HYA expression and of these 6 were H-Y positive. Of the three patients showing Yq structural abnormalities, two could be tested for H-Y expression and one was negative, the other positive. These results therefore show no correlation between spermatogenic failure and the absence of HYA, thus separating the AZF locus from HYA.
INTRODUCTION
Α genetic region Controlling spermatogenesis in humans has been localized to the long arm of the Υ chromosome [1] [2] [3] [4] [5] [6] [7] , as has the gene(s) encoding the minor histocompatibility antigen, HYA [8 -10] . In mice, the functional equivalent of the human azoospermia factor, AZF, is Spy and has been localized between Zfy-1 and Zfy-2 on the short arm of the Υ chromosome and its translocated counterpart, Sxr 1 [11, 12] . The Sxr b mutation arose by a gene fusion of Zfy-1 and Zfy-2, deleting the intervening DNA in which Hya, as well as Spy, is located [13] [14] [15] . The Sxr b mutation did not affect the testis determining gene Tdy/Sry, also present on the short arm of the murine Υ chromosome [16] and on Sxr 1 [13] , thus separating Hya from Sry [13, 7] . In man, HYA and TDF/SRY have also been separated by different chromosomal localization. It has been proposed that the functions of Spy and Hya in mice may be encoded by the same gene [ 12] , although a recombinant beiween Sxr 3 and Sxr b challenges this hypothesis [18] . In this paper, we examine the hypothesis that, in humans, AZF and HYA are the same gene, by testing a series of azoospermic or severely oligospermic men for the expression of HYA. The results show no correlation between spermatogenic failure and the absence of HYA, either in men with apparently normal 46 XY karyotypes, or with Yq structural anomalies, thus separating AZF from HYA.
RESULTS
The chromosomal constitution, clinical details and testicular histology of 9 sterile men with cytogenetically normal Υ chromosomes and three with Yq structural anomalies are shown in Table 1 , together with a summary of the H-Y phenotyping results of the 9 of them which could be typed, as they expressed the HLA-A2 or B7 allele used as the restriction molecule by our H-Y specific Τ cell clones. Details of the H-Y assays are shown in Table 2 . Six of the seven patients with cytogenetically normal Υ chromosomes who could be typed for H-Y were positive: one of the seven, KLARD, who has been previously reported to have a microdeletion in distal interval 6 of Yq [7] , was H-Y negative. Another, 'JOLAR', who had a microdeletion in proximal interval 6, typed H-Y positive. Two of the three azoospermic patients with Yq structural anomalies, FRABO and BITRA, could be typed for the presence of H-Y: FRABO was positive and BITRA negative. Thus, all but two of the nine HL Α A2 or B7 sterile patients, some with known deletions in the AZF region, had normal expression of HYA.
DISCUSSION
The finding of HYA expression in all but two of the nine sterile patients tested excludes the possibility that HYA and AZF are the same gene. Although they can both be localized to the same deletion interval of Yq [7, 10] , this still represents a large physical distance which could readily accommodate many genes. Molecular analyses of Yq deletions in 4 of the azoospermic patients reported here (JOWAL, BITRA, FRABO AND KLARD) have shown absence of a common contiguous length of DNA extending through three sub-intervals of interval 6 [7] . Of the three of these who could be typed by H-Y, one was positive, two negative, making it unlikely that HYA is located in the interval implicated for AZF. Α fifth azoospermic deletion patient, 'JOLAR', showed absence of a more proximal subinterval of interval 6 [7] which might also be implicated in spermatogenic control. He, too, typed H-Y positive. Current work is focused on a more detailed molecular analysis of the appropriate intervals of Yq, to make more precise localizations and to identify and test candidate genes, both for HYA, for which in vitro expression testing is available, and for AZF, which requires clinical correlates, but for which candidate genes can ultimately be tested in transgenic mice of the XOSxr b genetic constitution [12, 17] . 
MATERIALS AND METHODS

Selection of patients for screening
Amongst men undergoing investigation at an mfertility climc, twelve were selected with non-obstrucüve ohgo or azoospermia Nme were chromosomally normal, the other three havmg structural anomalies of the Υ chromosome (Table 1 ) On clnucal examniation, most patients had reduced testis volumes and raised levels of FSH and LH mdicative of spermatogemc unpairment Nine of the patients underwent testicular biopsy in the course of their mfertility mvestigations, the vanous histological findings included 'Sertoh-cell only' syndrome, spermatogemc depression and germ-cell maturation arrest
Molecular investigations
All nine of the chromosomally normal men tested for Η Υ were also investigated using interval 6 probes to detect possible microdeletions in the AZF region Two patients, 'JOLAR' and 'KLARD', were found to have non-overlappmg interruptions in their DNA, the microdeletion ni 'JOLAR' being proximal in interval 6, that in 'KLARD' being more distal [7] Both men displayed similar phenotypes of mfertility (see Table 1 ), raismg the possibihty that AZF might be one very large gene or that several genes residing on the Υ chromosome long arm might be important in spermatogenesis Microdeletions were not found in the other seven individuals tested H-Y typing EBV cell hnes from each of the patients shown in Table 1 were serotyped for HLA class I alleles of the Α and Β locus by Standard serotyping in the üssue typing laboratory of RPMS, by Mr Nick Davey and by FACS analysis at the CRC using the HLA A2 specific monoclonal antibody, HB82 (BB7 2) and the HLA B7 (crossreactive with B40) monoclonal antibody, HB57 (HB40 2) Expression of HLA-A2 and B7 alloantigens identified by Τ cells was confirmed by cytotoxic Τ cell lysis (CTL) expenments in which the patients' cells were also typed for H-Y, using EBV cell hnes from each of the patients and normal male and female appropnate controls The cytotoxicity was measured in a 51 Cr release assay as previously descnbed [8] The identity of the HLA molecule used as a restnction element for the detection of H-Y anügen in the CTL assays IS underhned in the HLA serotyping columns Figures underhned m the percent cytotoxicity columns are those showing significant levels of lysis at an attacker target (A T) ratio of 10 1, taken from regression analysis of data obtamed from a titration curve using 3 or 4 Α Τ ratios ND = not done Table 2 . Details of HLA serotyping and cytotoxic Τ cell phenotyping of EBV lines from patients and controls
